figshare
Browse
crc-23-0319_fig5.png (408.63 kB)

FIGURE 5 from Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-specific Neutrophils

Download (408.63 kB)
figure
posted on 2024-02-29, 14:21 authored by Rana Fetit, Alistair S. McLaren, Mark White, Megan L. Mills, John Falconer, Xabier Cortes-Lavaud, Kathryn Gilroy, Tamsin R.M. Lannagan, Rachel A. Ridgway, Colin Nixon, Varushka Naiker, Renee Njunge, Cassie J. Clarke, Declan Whyte, Kristina Kirschner, Rene Jackstadt, Jim Norman, Leo M. Carlin, Andrew D. Campbell, Owen J. Sansom, Colin W. Steele

Loss of neutrophil-specific CXCR2 attenuates suppression of T-cell proliferation in neutrophils from the metastatic niche in mice bearing tumors. Neutrophils from the liver and blood of littermate mice either Mrp8-Cre-Cxcr2+/+ (WT) or Mrp8-Cre-Cxcr2fl/fl (CXCR2fl) mice were harvested 28 days following intrasplenic injection of villinCreER KrasG12D/+Trp53fl/flRosa26N1CD/+ (KPN) cells. These were placed in coculture with T cells from WT mice, and analyzed through flow cytometry 44 hours later. A, Flow cytometry gating of T cells and neutrophils from coculture. Cells were gated on FSC-A/SSC-A (not shown), FCS-A/FSC-H for singlets, Live/Dead, CD3, and CD4/CD8 to define CD3+, CD3+/CD4+, and CD3+/CD8+ populations for analysis. Cell trace yellow allows for tracking of T-cell proliferation. The signal for each T-cell division becomes subsequently dimmer, and allows for calculation of the number of T-cell generations. Gating obtained from CXCR2fl mouse (blue) and unstimulated T cell control (red). B, Proportion of CD3+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers (BJ, four replicates from 2 WT mice and six replicates from 3 CXCR2fl mice). C, Expansion index of CD3+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. D, Division index of CD3+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. E, Proportion of CD4+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. F, Expansion index of CD4+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. G, Division index of CD4+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. H, Proportion of CD8+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. I, Expansion index of CD8+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. J, Division index of CD8+ T cells in coculture with WT and CXCR2fl neutrophils from tumor-bearing livers. K, Proportion of CD3+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice (KS, three replicates from 2 WT mice and four replicates from 2 CXCR2fl mice). L, Expansion index of CD3+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. M, Division index of CD3+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. N, Proportion of CD4+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. O, Expansion index of CD4+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. P, Division index of CD4+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. Q, Proportion of CD8+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. R, Expansion index of CD8+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. S, Division index of CD8+ T cells that proliferated in coculture with WT and CXCR2fl neutrophils from blood of tumor-bearing mice. *, P < 0.05 on unpaired t test. **, P < 0.01 on unpaired t test.

Funding

UK Research and Innovation (UKRI)

Cancer Research UK (CRUK)

Blood Cancer UK

UKRI | Medical Research Council (MRC)

CRUK | Beatson Institute for Cancer Research (The Beatson Institute)

History

ARTICLE ABSTRACT

Neutrophils are a highly heterogeneous cellular population. However, a thorough examination of the different transcriptional neutrophil states between health and malignancy has not been performed. We utilized single-cell RNA sequencing of human and murine datasets, both publicly available and independently generated, to identify neutrophil transcriptomic subtypes and developmental lineages in health and malignancy. Datasets of lung, breast, and colorectal cancer were integrated to establish and validate neutrophil gene signatures. Pseudotime analysis was used to identify genes driving neutrophil development from health to cancer. Finally, ligand–receptor interactions and signaling pathways between neutrophils and other immune cell populations in primary colorectal cancer and metastatic colorectal cancer were investigated. We define two main neutrophil subtypes in primary tumors: an activated subtype sharing the transcriptomic signatures of healthy neutrophils; and a tumor-specific subtype. This signature is conserved in murine and human cancer, across different tumor types. In colorectal cancer metastases, neutrophils are more heterogeneous, exhibiting additional transcriptomic subtypes. Pseudotime analysis implicates IL1β/CXCL8/CXCR2 axis in the progression of neutrophils from health to cancer and metastasis, with effects on T-cell effector function. Functional analysis of neutrophil-tumoroid cocultures and T-cell proliferation assays using orthotopic metastatic mouse models lacking Cxcr2 in neutrophils support our transcriptional analysis. We propose that the emergence of metastatic-specific neutrophil subtypes is driven by the IL1β/CXCL8/CXCR2 axis, with the evolution of different transcriptomic signals that impair T-cell function at the metastatic site. Thus, a better understanding of neutrophil transcriptomic programming could optimize immunotherapeutic interventions into early and late interventions, targeting different neutrophil states. We identify two recurring neutrophil populations and demonstrate their staged evolution from health to malignancy through the IL1β/CXCL8/CXCR2 axis, allowing for immunotherapeutic neutrophil-targeting approaches to counteract immunosuppressive subtypes that emerge in metastasis.